Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Rapid and effective control of malignancy-associated hyperuricemia achieved on rasburicase

July 20, 2001

Hormos presents new series of SERMs and their potential uses

July 19, 2001

Novartis discovers potential new class of antidiabetic agents

July 19, 2001

Selective ERbeta receptor agonists claimed for use in osteoporosis

July 18, 2001

Aventis gains license to Asta Medica's dexlipotam

July 18, 2001

Thyroid disease therapy now available in Japan

July 18, 2001

Genome Therapeutics and Wyeth-Ayerst extend osteoporosis genomics alliance

July 18, 2001

Vevesca enters U.S. trial for Gaucher's disease

July 17, 2001

New England Journal of Medicine publishes pivotal data for Fabrazyme

July 17, 2001

Potent and selective antagonists of neuropeptide Y5 receptors identified at Shionogi

July 16, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...